All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit Know AML.
Bookmark this article
The AML Hub is pleased to present a visual abstract highlighting key updates and changes in the 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms. Updates are focused on the increased separation between AML types defined by genetic abnormalities and those defined by differentiation, while still recognizing the impact and integration of clinical, molecular/genetic, and pathological factors.
To download this visual abstract, click below.Download here
SNDX-5613 shows encouraging overall response rate in relapsed/refractory acute leukemias
SNDX-5613, a potent, highly selective, oral inhibitor of the menin-mixed lineage leukemia (MLL) binding interaction, is currently under investigation in the...
1st NCRI AML academy meeting
During the 1st NCRI AML academy meeting, Professor Brian Huntly from the University of Cambridge, Cambridge, UK delivered a presentation detailing how genetic studies can facilitate clinical decision making in terms of...
Subscribe to get the best content related to AML delivered to your inbox